{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:50:41Z","timestamp":1755795041024,"version":"3.44.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,16]]},"DOI":"10.7759\/cureus.90224","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T14:48:18Z","timestamp":1755355698000},"source":"Crossref","is-referenced-by-count":0,"title":["Hinchey Stage IV Diverticulitis in a Kratom User"],"prefix":"10.7759","author":[{"given":"Mitchell","family":"Stout","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Gioe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.015","article-title":"Burden of digestive diseases in the United States part II: lower gastrointestinal diseases","volume":"136","author":"Everhart JE","year":"2009","unstructured":"Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology. 2009, 136:741-54. 10.1053\/j.gastro.2009.01.015","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3690202","article-title":"The natural history of incidental colonic diverticulosis on screening colonoscopy","volume":"2018","author":"Sharara AI","year":"2018","unstructured":"Sharara AI, Ziade N, Shayto RH, et al.. The natural history of incidental colonic diverticulosis on screening colonoscopy. Can J Gastroenterol Hepatol. 2018, 2018:3690202. 10.1155\/2018\/3690202","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref3","article-title":"Diagnosis and management of acute diverticulitis","volume":"87","author":"Wilkins T","year":"2013","unstructured":"Wilkins T, Embry K, George R. Diagnosis and management of acute diverticulitis. Am Fam Physician. 2013, 87:612-20.","journal-title":"Am Fam Physician"},{"key":"ref4","article-title":"Treatment of perforated diverticular disease of the colon","volume":"12","author":"Hinchey EJ","year":"1978","unstructured":"Hinchey EJ, Schaal PG, Richards GK. Treatment of perforated diverticular disease of the colon. Adv Surg. 1978, 12:85-109.","journal-title":"Adv Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-019-06882-z","article-title":"EAES and SAGES 2018 consensus conference on acute diverticulitis management: evidence-based recommendations for clinical practice","volume":"33","author":"Francis NK","year":"2019","unstructured":"Francis NK, Sylla P, Abou-Khalil M, et al.. EAES and SAGES 2018 consensus conference on acute diverticulitis management: evidence-based recommendations for clinical practice. Surg Endosc. 2019, 33:2726-41. 10.1007\/s00464-019-06882-z","journal-title":"Surg Endosc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111215","article-title":"The neuropharmacology of kratom, a novel psychoactive natural product","volume":"136","author":"Green M","year":"2025","unstructured":"Green M, Veltri CA, Prozialeck WC, Grundmann O. The neuropharmacology of kratom, a novel psychoactive natural product. Prog Neuropsychopharmacol Biol Psychiatry. 2025, 136:111215. 10.1016\/j.pnpbp.2024.111215","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/add.15082","article-title":"Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study","volume":"116","author":"Schimmel J","year":"2021","unstructured":"Schimmel J, Amioka E, Rockhill K, Haynes CM, Black JC, Dart RC, Iwanicki JL. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study. Addiction. 2021, 116:176-81. 10.1111\/add.15082","journal-title":"Addiction"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.19nr02507","article-title":"Kratom (Mitragyna speciosa): friend or foe?","volume":"22","author":"Sethi R","year":"2020","unstructured":"Sethi R, Hoang N, Ravishankar DA, McCracken M, Manzardo AM. Kratom (Mitragyna speciosa): friend or foe?. Prim Care Companion CNS Disord. 2020, 22:19nr02507. 10.4088\/PCC.19nr02507","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-020-00151-x","article-title":"Kratom-pharmacology, clinical implications, and outlook: a comprehensive review","volume":"9","author":"Eastlack SC","year":"2020","unstructured":"Eastlack SC, Cornett EM, Kaye AD. Kratom-pharmacology, clinical implications, and outlook: a comprehensive review. Pain Ther. 2020, 9:55-69. 10.1007\/s40122-020-00151-x","journal-title":"Pain Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2017.07.002","article-title":"Mu-opioid receptor biased ligands: a safer and painless discovery of analgesics?","volume":"22","author":"Madariaga-Maz\u00f3n A","year":"2017","unstructured":"Madariaga-Maz\u00f3n A, Marmolejo-Valencia AF, Li Y, Toll L, Houghten RA, Martinez-Mayorga K. Mu-opioid receptor biased ligands: a safer and painless discovery of analgesics?. Drug Discov Today. 2017, 22:1719-29. 10.1016\/j.drudis.2017.07.002","journal-title":"Drug Discov Today"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2280","article-title":"Kratom use and toxicities in the United States","volume":"39","author":"Eggleston W","year":"2019","unstructured":"Eggleston W, Stoppacher R, Suen K, Marraffa JM, Nelson LS. Kratom use and toxicities in the United States. Pharmacotherapy. 2019, 39:775-7. 10.1002\/phar.2280","journal-title":"Pharmacotherapy"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.08.013","article-title":"Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa","volume":"549","author":"Matsumoto K","year":"2006","unstructured":"Matsumoto K, Hatori Y, Murayama T, et al.. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa. Eur J Pharmacol. 2006, 549:63-70. 10.1016\/j.ejphar.2006.08.013","journal-title":"Eur J Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2012.11.012","article-title":"From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction","volume":"37","author":"Hassan Z","year":"2013","unstructured":"Hassan Z, Muzaimi M, Navaratnam V, et al.. From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neurosci Biobehav Rev. 2013, 37:138-51. 10.1016\/j.neubiorev.2012.11.012","journal-title":"Neurosci Biobehav Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199512000-00002","article-title":"The emerging role of cytochrome P450 3A in psychopharmacology","volume":"15","author":"Ketter TA","year":"1995","unstructured":"Ketter TA, Flockhart DA, Post RM, et al.. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol. 1995, 15:387-98. 10.1097\/00004714-199512000-00002","journal-title":"J Clin Psychopharmacol"},{"key":"ref15","article-title":"Kratom","author":"Jentsch MJ","year":"2025","unstructured":"Jentsch MJ, Pippin MM. Kratom. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6814a2","article-title":"Notes from the field: unintentional drug overdose deaths with kratom detected-27 States, July 2016-December 2017","volume":"68","author":"Olsen EO","year":"2019","unstructured":"Olsen EO, O'Donnell J, Mattson CL, Schier JG, Wilson N. Notes from the field: unintentional drug overdose deaths with kratom detected-27 States, July 2016-December 2017. MMWR Morb Mortal Wkly Rep. 2019, 68:326-7. 10.15585\/mmwr.mm6814a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp161035","article-title":"Pharmacologic and clinical assessment of kratom","volume":"75","author":"White CM","year":"2018","unstructured":"White CM. Pharmacologic and clinical assessment of kratom. Am J Health Syst Pharm. 2018, 75:261-7. 10.2146\/ajhp161035","journal-title":"Am J Health Syst Pharm"},{"key":"ref18","article-title":"Kratom: Summary of State Laws","author":"Legislative Analysis and Public Policy Association","year":"2022","unstructured":"Legislative Analysis and Public Policy Association. Kratom: Summary of State Laws. Legislative Analysis and Public Policy Association, Washington, D.C.; 2022. https:\/\/legislativeanalysis.org\/wp-content\/uploads\/2022\/12\/Kratom-Summary-of-State-Laws.pdf."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/add.16366","article-title":"Not all kratom is equal: the important distinction between native leaf and extract products","volume":"119","author":"Grundmann O","year":"2024","unstructured":"Grundmann O, Garcia-Romeu A, McCurdy CR, Sharma A, Smith KE, Swogger MT, Weiss ST. Not all kratom is equal: the important distinction between native leaf and extract products. Addiction. 2024, 119:202-3. 10.1111\/add.16366","journal-title":"Addiction"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2015.03.020","article-title":"A cross-sectional study of provider and patient characteristics associated with outpatient disclosures of dietary supplement use","volume":"98","author":"Tarn DM","year":"2015","unstructured":"Tarn DM, Karlamangla A, Coulter ID, et al.. A cross-sectional study of provider and patient characteristics associated with outpatient disclosures of dietary supplement use. Patient Educ Couns. 2015, 98:830-6. 10.1016\/j.pec.2015.03.020","journal-title":"Patient Educ Couns"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382367-hinchey-stage-iv-diverticulitis-in-a-kratom-user","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T14:48:18Z","timestamp":1755355698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382367-hinchey-stage-iv-diverticulitis-in-a-kratom-user"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.90224","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,16]]}}}